Yahoo
OTC Markets OTCPK - Delayed Quote USD

Affymax, Inc. (AFFY)

0.0008 0.0000 (0.00%)
At close: November 6 at 4:00:00 PM EST
Chart Range Bar
Loading chart for AFFY
  • Previous Close 0.0008
  • Open 0.0009
  • Bid --
  • Ask --
  • Day's Range 0.0009 - 0.0009
  • 52 Week Range 0.0007 - 0.0416
  • Volume 6,000
  • Avg. Volume 1,169
  • Market Cap (intraday) 29,992
  • Beta (5Y Monthly) 3.08
  • PE Ratio (TTM) --
  • EPS (TTM) 0.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.

2

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

AFFY
0.00%
S&P 500 (^GSPC)
7.76%

1-Year Return

AFFY
11.11%
S&P 500 (^GSPC)
9.77%

3-Year Return

AFFY
100.00%
S&P 500 (^GSPC)
68.96%

5-Year Return

AFFY
60.00%
S&P 500 (^GSPC)
57.04%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY13
Revenue 844k
Earnings -26.67M
Profit Margin -3,160.43%

Q2

FY12

Q3

FY12

Q4

FY12

Q1

FY13

-60M
-40M
-20M
0
-3000.0%
-2000.0%
-1000.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7,300.00%

  • Return on Assets (ttm)

    -228.91%

  • Return on Equity (ttm)

    111.59%

  • Revenue (ttm)

    42k

  • Net Income Avi to Common (ttm)

    3.07M

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.4M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -41.41M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: